In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CardioDx gets $34.6mm through Series D venture round

Executive Summary

CardioDx Inc. (developing cardiovascular diagnostics) has brought in $34.6mm of a potential $44.5mm Series D venture round. GE Healthcare led the financing with a $5mm investment through its newly formed Healthymagination Fund. Fellow first-time backer DAG Ventures was joined by current shareholders Asset Management, Kleiner Perkins Caufield & Byers, Intel Capital, Mohr Davidow Ventures, Pappas Ventures, and TPG Ventures, as well as seven other undisclosed investors.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies